Literature DB >> 31585683

Practical Guide to Vaccination in All Stages of CKD, Including Patients Treated by Dialysis or Kidney Transplantation.

Karen M Krueger1, Michael G Ison2, Cybele Ghossein3.   

Abstract

Infection is a major cause of morbidity and mortality in patients with chronic kidney disease (CKD), including those receiving maintenance dialysis or with a kidney transplant. Although responses to vaccines are impaired in these populations, immunizations remain an important component of preventative care due to their favorable safety profiles and the high rate of infection in these patients. Most guidelines for patients with CKD focus on the importance of the hepatitis B, influenza, and pneumococcal vaccines in addition to age-appropriate immunizations. More data are needed to determine the clinical efficacy of these immunizations and others in this population and define optimal dosing and timing for administration. Studies have suggested that there may be a benefit to immunization before the onset of dialysis or transplantation because patients with early-stage CKD generally have higher rates of seroconversion. Because nephrologists often serve as primary care physicians for patients with CKD, it is important to understand the role of vaccinations in the preventive care of this patient population.
Copyright © 2019 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vaccination; chronic kidney disease (CKD); cytomegalovirus (CMV); dialysis; end-stage renal disease (ESRD); hepatitis B virus; immunization schedule; immunocompromised travelers; immunogenicity; infectious disease; influenza; kidney transplant recipient; meningococcal disease; pneumococcal disease; review; seroprotection; shingles; varicella zoster virus (VZV)

Mesh:

Year:  2019        PMID: 31585683     DOI: 10.1053/j.ajkd.2019.06.014

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  43 in total

1.  Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.

Authors:  Emilio Sánchez-Álvarez; Borja Quiroga; Patricia de Sequera
Journal:  Nefrologia (Engl Ed)       Date:  2021-01-01

Review 2.  Urological Cancers and Kidney Transplantation: a Literature Review.

Authors:  Cristian Axel Hernández-Gaytán; Francisco Rodríguez-Covarrubias; Ricardo A Castillejos-Molina; Andrés Hernández-Porras; Ignacio Tobia; Justin M Dubin; Ana María Autrán-Gómez
Journal:  Curr Urol Rep       Date:  2021-12-16       Impact factor: 3.092

3.  Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.

Authors:  Thilo Kolb; Svenja Fischer; Lisa Müller; Nadine Lübke; Jonas Hillebrandt; Marcel Andrée; Michael Schmitz; Claudia Schmidt; Seher Küçükköylü; Lynn Koster; Margarethe Kittel; Lea Weiland; Karl W Dreyling; Gerd Hetzel; Ortwin Adams; Heiner Schaal; Katrin Ivens; Lars C Rump; Jörg Timm; Johannes Stegbauer
Journal:  Kidney360       Date:  2021-07-13

4.  Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.

Authors:  Jens Van Praet; Marijke Reynders; Dirk De Bacquer; Liesbeth Viaene; Melanie K Schoutteten; Rogier Caluwé; Peter Doubel; Line Heylen; Annelies V De Bel; Bruno Van Vlem; Deborah Steensels; An S De Vriese
Journal:  J Am Soc Nephrol       Date:  2021-09-29       Impact factor: 10.121

5.  Improving influenza and pneumococcal vaccination uptake among incident peritoneal dialysis patients: a quality improvement initiative.

Authors:  Hui Zhuan Tan; Chee Chin Phang; Sin Yan Wu; Mui Hian Sim; Michelle Meixin Law; Marjorie Wai Yin Foo; Htay Htay
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

6.  Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD.

Authors:  Edward J Carr; Andreas Kronbichler; Matthew Graham-Brown; Graham Abra; Christos Argyropoulos; Lorraine Harper; Edgar V Lerma; Rita S Suri; Joel Topf; Michelle Willicombe; Swapnil Hiremath
Journal:  Kidney Int Rep       Date:  2021-07-06

7.  The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.

Authors:  Emanuel Zitt; Tamara Davidovic; Judith Schimpf; Armin Abbassi-Nik; Beatrix Mutschlechner; Hanno Ulmer; Magdalena A Benda; Hannelore Sprenger-Mähr; Thomas Winder; Karl Lhotta
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

8.  COVID-19 and Dialysis Patients: Unsolved Problems in Early 2021.

Authors:  Alan S Kliger; Jeffrey Silberzweig
Journal:  J Am Soc Nephrol       Date:  2021-02-26       Impact factor: 10.121

9.  Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients.

Authors:  Dominique Bertrand; Mouad Hamzaoui; Veronique Lemée; Julie Lamulle; Mélanie Hanoy; Charlotte Laurent; Ludivine Lebourg; Isabelle Etienne; Mathilde Lemoine; Frank Le Roy; Dorian Nezam; Jean-Christophe Plantier; Olivier Boyer; Dominique Guerrot; Sophie Candon
Journal:  J Am Soc Nephrol       Date:  2021-06-10       Impact factor: 14.978

10.  Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.

Authors:  Clément Danthu; Sébastien Hantz; Arthur Dahlem; Marion Duval; Bacary Ba; Manon Guibbert; Zhour El Ouafi; Séverine Ponsard; Insaf Berrahal; Jean-Michel Achard; Frédérique Bocquentin; Vincent Allot; Jean-Philippe Rerolle; Sophie Alain; Fatouma Touré
Journal:  J Am Soc Nephrol       Date:  2021-06-16       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.